Gilead Clarifies Quad Will Come First, Over Detailing For Triple Combo Complera
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Company is pursuing priority review, eyes FDA approval in mid-2012. If Quad is cleared, newly approved Complera will take back seat.